PHARMAPHIE HOLDING: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAPHIE HOLDING
Largest movements
- Receivables after one year -€34,102
down €34,102 (-9.1%), from €375,000 to €340,898
- Receivables within one year +€28,722
up €28,722 (+601%), from €4,777 to €33,499
of which Trade receivables: +€30,250
- Other debts +€37,336
up €37,336 (+19.0%), from €196,546 to €233,883
- Debts after one year -€30,819
down €30,819 (-2.2%), from €1.4m to €1.4m
- Gross operating margin -€31,294
down €31,294 (-48.0%), from €65,143 to €33,848
- Taxes -€10,524
down €10,524 (-77.6%), from €13,556 to €3,032
- Financial income -€5,218
down €5,218 (-17.1%), from €30,496 to €25,278
- Financial charges -€4,393
down €4,393 (-8.2%), from €53,882 to €49,489
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,377,155 | €2,385,765 | +€8,610 | +0.4% |
| Fixed assets | 21/28 | €1,915,359 | €1,915,359 | = | 0.0% |
| Financial fixed assets | 28 | €1,915,359 | €1,915,359 | = | 0.0% |
| Current assets | 29/58 | €461,796 | €470,406 | +€8,610 | +1.9% |
| Amounts receivable after more than one year | 29 | €375,000 | €340,898 | -€34,102 | -9.1% |
| Other amounts receivable | 291 | €375,000 | €340,898 | -€34,102 | -9.1% |
| Amounts receivable within one year | 40/41 | €4,777 | €33,499 | +€28,722 | +601% |
| Trade receivables | 40 | - | €30,250 | +€30,250 | |
| Other amounts receivable | 41 | €4,777 | €3,249 | -€1,528 | -32.0% |
| Cash at bank and in hand | 54/58 | €52,238 | €69,426 | +€17,188 | +32.9% |
| Deferred charges and accrued income | 490/1 | €29,780 | €26,583 | -€3,198 | -10.7% |
| Total equity and liabilities | 10/49 | €2,377,155 | €2,385,765 | +€8,610 | +0.4% |
| Equity | 10/15 | €700,570 | €705,767 | +€5,196 | +0.7% |
| Contributions | 10/11 | €487,500 | €487,500 | = | 0.0% |
| Reserves | 13 | €213,070 | €218,267 | +€5,196 | +2.4% |
| Non-distributable reserves | 130/1 | €4,699 | €4,699 | = | 0.0% |
| Reserves not available under the articles | 1311 | €4,699 | €4,699 | = | 0.0% |
| Distributable reserves | 133 | €208,371 | €213,567 | +€5,196 | +2.5% |
| Amounts payable | 17/49 | €1,676,585 | €1,679,998 | +€3,413 | +0.2% |
| Amounts payable after more than one year | 17 | €1,418,319 | €1,387,500 | -€30,819 | -2.2% |
| Financial debts | 170/4 | €1,418,319 | €1,387,500 | -€30,819 | -2.2% |
| Amounts payable within one year | 42/48 | €204,766 | €243,027 | +€38,261 | +18.7% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Trade debts | 44 | €5,558 | €6,333 | +€774 | +13.9% |
| Suppliers | 440/4 | €5,558 | €6,333 | +€774 | +13.9% |
| Taxes, remuneration and social security | 45 | €2,661 | €2,812 | +€151 | +5.7% |
| Taxes | 450/3 | €2,661 | €2,812 | +€151 | +5.7% |
| Other amounts payable | 47/48 | €196,546 | €233,883 | +€37,336 | +19.0% |
| Accrued charges and deferred income | 492/3 | €53,500 | €49,472 | -€4,029 | -7.5% |
| Other operating charges | 640/8 | €1,366 | €1,409 | +€43 | +3.2% |
| Non-recurring operating charges | 66A | €236 | €0 | -€236 | -100% |
| Gross operating margin | 9900 | €65,143 | €33,848 | -€31,294 | -48.0% |
| Operating profit (loss) | 9901 | €63,541 | €32,439 | -€31,102 | -48.9% |
| Financial income | 75/76B | €30,496 | €25,278 | -€5,218 | -17.1% |
| Recurring financial income | 75 | €30,496 | €25,278 | -€5,218 | -17.1% |
| Financial charges | 65/66B | €53,882 | €49,489 | -€4,393 | -8.2% |
| Recurring financial charges | 65 | €53,882 | €49,489 | -€4,393 | -8.2% |
| Profit (loss) for the period before taxes | 9903 | €40,155 | €8,228 | -€31,927 | -79.5% |
| Income taxes | 67/77 | €13,556 | €3,032 | -€10,524 | -77.6% |
| Profit (loss) for the period | 9904 | €26,599 | €5,196 | -€21,402 | -80.5% |
| Profit (loss) for the period to be appropriated | 9905 | €26,599 | €5,196 | -€21,402 | -80.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.